References
1. Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada System). Cancer. 1999;86:364-372.
2. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma. N Engl J Med. 1985;313:1111-1116.
3. Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol. 1991;9:581-591.
4. Shimada H, Stram DO, Chatten J, et al. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst. 1995;87:1470-1476.
5. John MM, Michael DH, Susan C, et al. Neuroblastoma. Lancet. 2007; 369: 2106-20.
6. Suganuma R, Larry L. W, Shimada H, et al. Peripheral Neuroblastic Tumors with Genotype-Phenotype Discordance: A Report from the Children’s Oncology Group and the International Neuroblastoma Pathology Committee. Pediatr Blood Cancer. 2013;60:363-370.
7. Takahiro G, Hajime H, Tomoko I, et al. Prediction of MYCN Amplification in Neuroblastoma Using Serum DNA and Real-Time Quantitative Polymerase Chain Reaction. J Clin Oncol. 2005;23:5205-5210.
8.Susan GK, Robert CS, Judith GV, et al. Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial. Lancet Oncol. 2013;14:999-1008.
9. Cohn SL, Herst CV, Maurer HS, et al. N-myc amplification in an infant with stage IVS neuroblastoma. J Clin Oncol. 1987;5:1441-1444.
10. Katzenstein HM, Bowman LC, Brodeur GM, et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: The Pediatric Oncology Group Experience – A Pediatric Oncology Group Study. J Clin Oncol. 1998;16:2007-2017.
11. Shimada H, Nakagawa A, Peters J, et al. Trk A expression in peripheral neuroblastic tumors: prognostic significance and biological relevance. Cancer 2004; 101: 1873-1881
12. Chan EL, Harris ER, Emery HK, et al. Favorable histology, MYCN-amplified 4S neonatal neuroblastoma. Pediatr Blood Cancer. 2007;48:479-482.
13. Goto S, Umehara S, Gerbing RB, et al. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors. Cancer. 2001;92:2699-2708.
14. Elizabeth S, Ami VD, Wendy BL, et al. Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project. J Clin Oncol. 38;17:1906-1918.